GSM5958018|N/A|N/A|N/A|N/A|N/A|pituitary adenoma|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958019|N/A|N/A|N/A|N/A|N/A|astrocytoma, IDH-mutant, WHO grade 3|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958020|N/A|N/A|N/A|N/A|N/A|atypical meningioma, WHO Grade 2|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958021|N/A|N/A|N/A|N/A|N/A|glioblastoma, IDH-wildtype, WHO grade 4|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958022|N/A|N/A|N/A|N/A|N/A|Hemangioblastoma, WHO grade 1|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958023|N/A|N/A|N/A|N/A|N/A|meningioma, WHO grade 1|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958024|N/A|N/A|N/A|N/A|N/A|Choroid plexus papilloma, WHO grade 1|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958025|N/A|N/A|N/A|N/A|N/A|pineal parenchymal tumor of intermediate differentiation (PPTID), WHO grade 3|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958026|N/A|N/A|N/A|N/A|N/A|astrocytoma, IDH-mutant, WHO grade 3|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958027|N/A|N/A|N/A|N/A|N/A|Pituitary adenoma|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958028|N/A|N/A|N/A|N/A|N/A|Large cell/anaplastic medulloblastoma, WHO grade 4, SHH|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958029|N/A|N/A|N/A|N/A|N/A|dysembryoplastic neuroepithelial tumor, WHO grade 1|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958030|N/A|N/A|N/A|N/A|N/A|pilocytic astrocytoma, WHO grade 1|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958031|N/A|N/A|N/A|N/A|N/A|classic medulloblastoma with focal anaplasia, WHO grade 4, non-WNT/non-SHH|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958032|N/A|N/A|N/A|N/A|N/A|Choroid plexus papilloma, WHO grade 1|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958033|N/A|N/A|N/A|N/A|N/A|Glial neoplasm|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958034|N/A|N/A|N/A|N/A|N/A|Residual pleomorphic xanthoastrocytoma|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958035|N/A|N/A|N/A|N/A|N/A|pineal parenchymal tumor of intermediate differentiation (PPTID), WHO grade 3|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958036|N/A|N/A|N/A|N/A|N/A|astrocytoma, IDH-mutant, WHO grade 3|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958037|N/A|N/A|N/A|N/A|N/A|Pituitary adenoma|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958086|N/A|N/A|N/A|N/A|N/A|Recurrent anaplastic ependymoma, WHO grade 3|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958041|N/A|N/A|N/A|N/A|N/A|pleomorphic xanthoastrocytoma|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958042|N/A|N/A|N/A|N/A|N/A|pineal parenchymal tumor of intermediate differentiation (PPTID), WHO grade 3|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958101|N/A|N/A|N/A|N/A|N/A|Atypical teratoid/rhabdoid tumor|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958079|N/A|N/A|N/A|N/A|N/A|Recurrent/residual anaplastic oligodendroglioma, IDH-mutant (IHC), WHO grade 3|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958051|N/A|N/A|N/A|N/A|N/A|Atypical meningioma, WHO Grade 2|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958043|N/A|N/A|N/A|N/A|N/A|metastatic lung adenocarcinoma|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958097|N/A|N/A|N/A|N/A|N/A|Diffuse large B cell lymphoma|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958075|N/A|N/A|N/A|N/A|N/A|Residual/recurrent astrocytoma, IDH-mutant (R132G per previous molecular testing), at least WHO grade 3|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958084|N/A|N/A|N/A|N/A|N/A|Recurrent/residual glioblastoma, IDH-wildtype, WHO grade 4|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958057|N/A|N/A|N/A|N/A|N/A|Medulloblastoma|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958076|N/A|N/A|N/A|N/A|N/A|Metastatic adenocarcinoma, consistent with lung primary|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958060|N/A|N/A|N/A|N/A|N/A|Craniopharyngioma, adamantinomatous type, WHO grade 1|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958065|N/A|N/A|N/A|N/A|N/A|High grade malignancy favor glioblastoma, IDH-wildtype (IHC), WHO grade IV|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958054|N/A|N/A|N/A|N/A|N/A|Hemangioblastoma, WHO grade 1|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958038|N/A|N/A|N/A|N/A|N/A|Large cell/anaplastic medulloblastoma, WHO grade 4, SHH|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958070|N/A|N/A|N/A|N/A|N/A|Recurrent glioblastoma, IDH wild type (pyrosequencing), WHO grade 4|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958073|N/A|N/A|N/A|N/A|N/A|Metastatic melanoma|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958089|N/A|N/A|N/A|N/A|N/A|Hemangioblastoma, WHO grade 1|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958072|N/A|N/A|N/A|N/A|N/A|Pilocytic astrocytoma, WHO grade 1|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958050|N/A|N/A|N/A|N/A|N/A|astrocytoma, IDH-mutant, WHO grade 3|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958091|N/A|N/A|N/A|N/A|N/A|Schwannoma, WHO grade 1|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958048|N/A|N/A|N/A|N/A|N/A|Diffuse large B cell lymphoma|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958044|N/A|N/A|N/A|N/A|N/A|Meningioma, WHO grade 1|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958056|N/A|N/A|N/A|N/A|N/A|Schwannoma, WHO grade 1|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958047|N/A|N/A|N/A|N/A|N/A|classic medulloblastoma with focal anaplasia, WHO grade 4, non-WNT/non-SHH|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958040|N/A|N/A|N/A|N/A|N/A|pilocytic astrocytoma, WHO grade 1|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958071|N/A|N/A|N/A|N/A|N/A|Pilocytic astrocytoma, WHO grade 1|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958078|N/A|N/A|N/A|N/A|N/A|Recurrent/residual glioblastoma, IDH-wildtype (IHC), WHO grade 4|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958100|N/A|N/A|N/A|N/A|N/A|Ganglioglioma, WHO grade I|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958066|N/A|N/A|N/A|N/A|N/A|Subependymoma, WHO grade 1|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958062|N/A|N/A|N/A|N/A|N/A|Schwannoma, WHO grade 1|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958063|N/A|N/A|N/A|N/A|N/A|astrocytoma, IDH-mutant, WHO grade 3|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958068|N/A|N/A|N/A|N/A|N/A|Atypical meningioma, WHO grade 2|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958052|N/A|N/A|N/A|N/A|N/A|glioblastoma, IDH-wildtype, WHO grade 4|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958090|N/A|N/A|N/A|N/A|N/A|Schwannoma, WHO grade 1|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958053|N/A|N/A|N/A|N/A|N/A|Hemangioblastoma, WHO grade 1|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958055|N/A|N/A|N/A|N/A|N/A|meningioma, WHO grade 1|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958046|N/A|N/A|N/A|N/A|N/A|Pituitary adenoma|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958082|N/A|N/A|N/A|N/A|N/A|Ependymoma, WHO grade 2|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958081|N/A|N/A|N/A|N/A|N/A|High grade astrocytoma, IDH-wildtype (IHC), at least WHO grade 3|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958087|N/A|N/A|N/A|N/A|N/A|Papillary tumor of pineal region|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958069|N/A|N/A|N/A|N/A|N/A|Focal cortical dysplasia, type IIa|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958094|N/A|N/A|N/A|N/A|N/A|astrocytoma, IDH-mutant, WHO grade 3|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958045|N/A|N/A|N/A|N/A|N/A|Anaplastic oligodendroglioma, IDH-mutant (IHC), WHO grade 3|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958095|N/A|N/A|N/A|N/A|N/A|Atypical meningioma, WHO grade 2|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958067|N/A|N/A|N/A|N/A|N/A|Glioblastoma, IDH-wildtype (IHC), WHO grade 4|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958039|N/A|N/A|N/A|N/A|N/A|dysembryoplastic neuroepithelial tumor, WHO grade 1|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958092|N/A|N/A|N/A|N/A|N/A|Ependymoma, WHO grade 2|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958098|N/A|N/A|N/A|N/A|N/A|Pituitary adenoma|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958058|N/A|N/A|N/A|N/A|N/A|Large cell/anaplastic medulloblastoma, WHO grade 4, SHH|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958077|N/A|N/A|N/A|N/A|N/A|Metastatic adenocarcinoma, consistent with lung primary|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958085|N/A|N/A|N/A|N/A|N/A|pilocytic astrocytoma, WHO grade 1|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958061|N/A|N/A|N/A|N/A|N/A|Solitary fibrous tumor|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958074|N/A|N/A|N/A|N/A|N/A|Residual/recurrent astrocytoma, IDH-mutant (R132G per previous molecular testing), at least WHO grade 3|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958064|N/A|N/A|N/A|N/A|N/A|High grade malignancy favor glioblastoma, IDH-wildtype (IHC), WHO grade IV|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958083|N/A|N/A|N/A|N/A|N/A|Diffuse large B cell lymphoma|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958093|N/A|N/A|N/A|N/A|N/A|Ependymoma, WHO grade 2|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958088|N/A|N/A|N/A|N/A|N/A|Recurrent/residual glioblastoma, IDH-wildtype (IHC), WHO grade 4|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958099|N/A|N/A|N/A|N/A|N/A|Ganglioglioma, WHO grade I|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958059|N/A|N/A|N/A|N/A|N/A|classic medulloblastoma with focal anaplasia, WHO grade 4, non-WNT/non-SHH|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958080|N/A|N/A|N/A|N/A|N/A|Astrocytoma, IDH-mutant (IHC), at least WHO grade 3|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958096|N/A|N/A|N/A|N/A|N/A|High grade astrocytoma, IDH-wildtype (IHC), at least WHO grade 3|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease
GSM5958049|N/A|N/A|N/A|N/A|N/A|pituitary adenoma|Brain|N/A|in_vivo|N/A|N/A|N/A|Disease